Posts Tagged "cancer risk"

Obesity Drug Lorcaserin Turned Down By FDA Because Of "Cancer Risks"

Posted on Oct 25, 2010 in Uncategorized

Article Date: 24 Oct 2010 – 9:00 PDT Citing cancer risks as one of its reasons, lorcaserin, an experimental drug for obesity treatment and maintenance of weight loss, was turned down by the Food and Drug Administration (FDA). The FDA informed lorcaserin makers, Arena Pharmaceuticals Inc., in a Complete Response Letter (CRL) that it needs an independent review of the findings, as well as possibly further studies looking into the risk of tumors, which were found in animal studies (diagnostic uncertainty in the classification of mammary masses in female rats). The “marginal”...

Read More